1.A comparative effectiveness research on operative methods of femoral neck fractures in the elderly
Jin TANG ; Weichun GUO ; Ling YU ; Shenghao ZHAO
Clinical Medicine of China 2011;27(5):515-518
Objective To compare the effect of compression hollow screw fixation,artificial femoral head replacement and total hip replacement in the elderly.Methods From August 2007 to April 2009,152 cases of femoral neck fracture in the elderly were divided into three groups: compression hollow screw fixation group(54 patients,24 males,with an average age of 59.8±5.3 years);artificial femoral head replacement group(48 patients,16 males,with an average age of 65.3±6.7 years);and total hip replacement group(50 patients,18 males,with an average age of 77.3±6.5 years).The evaluation indicators,including the average sugical time,the average amount of bleeding,the average length of stay and the average postopererative bed time,were compared respectively among the three groups.The postoperative evaluation was made according to Harris Score.Results Harris score in the three groups were 21 excellent and 23 good in the compression hollow screw fixation group,with an average score of 80.52±2.70;26 excellent and 14 good in the artificial femoral head replacement group,with an average score of 86.57±1.90;and 42 excellent and 3 good in the total hip replacement group,with an average score of 96.04±2.10.The total hip replacement group was significantly better than the other two groups(H=0.589,F=12.151,Ps<0.05).The rate of postoperative complications were 25.93%(14/54) in the compression hollow screw fixation group,18.75%(9/48) in the artificial femoral head replacement group and 4.00%(2/50) in the total hip replacement group(H=1.291,P<0.05).Conclusion Compared among the three surgery,total hip replacement could resume function and improve the quality of life better,with lower rate of complications.However,the surgical injury and the amount of bleeding were largest.Therefore,we suggest selecting appropriate surgery with considering the patient′s age,physical condition,displacement degree of the fracture,et al.in old femoral neck fractures patients.
2.Characteristic of Liver Injury Induced by Simvastatin Combined with HRZ in SD Rats
Shenghao LI ; Jie CHEN ; Yingrong DU ; Mingli YU ; Jiangli PENG
Journal of Kunming Medical University 2016;37(7):1-5
Objective To study the characteristics of liver injury induced by simvastatin combined with HRZ (Isoniazid,Rifampicin and Pyrazinamide) in SD rats.Methods Fifty-four 8-week-old SD rats were randomly divided into 3 groups:group A (control),group B (HRZ) and group C (simvastatin combined to HRZ),half of each group were male.We calculated the accurate dose respectively before those rats were given intragastrical administration of corresponding drugs.Six rats were killed in each group on 10th,20th and 40th day,respectively.Before this,blood was fastened from femoral of every rat that would be killed to test liver function,liver tissue slices were made in order to observe the pathological characteristic.Results Alanine amiotransferase of group C elevated in line with time and reached statistic difference on 40th day,furthermore,it was significantly higher than group A (P<0.05).Total bilirubin and direct Bilirubin of group C were significantly higher than those of group A from the beginning to the end (P<0.05),however,they declined rapidly on 10th day,this trend also had statistic difference (P<0.05) At the end of this experiment,hepatic cords was disordered slightly,but swelling liver cells and vacuolar degeneration were observed,the nuleus of cell condensed.Soakage of monocytes,neutrophils,and lymphocytes occurred in the portal and lobule regions,or even spotty necrosis occasionally.Conclusion Cholestasis occurs at the early stage when simvastatin is combined with HRZ in SD rats,however,it has a rapidly degressive trend.In contrast,Alanine amiotransferase elevates,furthermore,pathological injury or even spotty necrosis can emerge in liver tissue slices.
3.Prediction of response of collagen-induced arthritis rats to methotrexate: An (1)H-NMR-based urine metabolomic analysis.
Zhe, CHEN ; Shenghao, TU ; Yonghong, HU ; Yu, WANG ; Yukun, XIA ; Yi, JIANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(3):438-43
Over one half the patients with rheumatoid arthritis (RA) are being treated with methotrexate (MTX). Although well proven, the efficacy of MTX varies in individual patients. This study examined the metabolic biomarkers that can be used to predict the therapeutic effect of MTX by using metabolomic analysis. Rats were immunized with collagen to rapidly cause collagen-induced arthritis (CIA) and then treated with 0.1 mg/kg MTX for 4 weeks. The clinical signs and the histopathological features of CIA were observed to evaluate the therapeutic effects. Urine samples of CIA rats were collected, and analyzed by using 600 M (1)H-nuclear magnetic resonance ((1)H-NMR) for spectral binning after the therapy. The urine spectra were divided into spectral bins, and 20 endogenous metabolites were assigned by Chenomx Suite. Multivariate analyses were performed to identify the spectral pattern of endogenous metabolites related to MTX therapy. The results showed that the clustering of the spectra of the urine samples from the responsive rats (n=20) was different from that from the non-responsive rats (n=11). Multivariate analysis showed difference in metabolic profiles between the responsive and non-responsive rats by using partial least squares-discrimination analysis (PLS-DA) (R(2)=0.812, Q(2)=0.604). In targeted profiling, 13 endogenous metabolites (uric acid, taurine, histidine, methionine, glycine, etc.) were selected as putative biomarkers for predicting therapeutic response to MTX. It was suggested that (1)H-NMR-based metabolomic analysis can be used to predict the therapeutic effect of MTX, and several metabolites were found to be related to the therapeutic effects of MTX.
4.Regulatory effect of triptolide on angiogenesis in synovium of collagen-induced arthritis rats
Zhe CHEN ; Yonghong HU ; Yu WANG ; Shenghao TU ; Peilin LIU ; Hong BA ; Xiaojuan GUO
Chinese Journal of Rheumatology 2008;12(4):254-257,插1
Objective To study the regulatory effect of triptolide(TP)on the angiogenesis of coll-agen-induced arthritis(CIA) rats.The effect of TP on arthritis is also explored.Methods After the model of CIA was established,the articular volume was measured and the synovium was examined with regular HE stainand the inflammation and pathological changes were evaluated.In addition,the vascular endothelial growth factor (VEGF),basic fibroblast growth factor (bFGF)and endostatin protein expressions in synovium and serum were tested.The micro-vessel density (MVD) of synovium was also measured by caulating CD34 level.Results The expressions of VEGF,bFGF and MVD in CIA rats'synovium and serum were evidently higher than the control group(X2=65.3,31.6,q=9.2,P<O.01,respectively),while the expression of endostatin showed no statistical difference with controls (X2=0.8,P>0.05).After treated with TP,the expressions of VEGF,bFGFand MVD decreased markedly(X2=19.7,6.0,q=6.5,P<O.01,respectively),but the pmtein expression of endostatin significantly increased (X2=3.9,P<O.05).However,only the expression of endostatin increased significantly after treated with MTX (X2=17.9,P<0.01).Conclusion Imbalance in growth factors prnduction may play an important role in the process of arthritis development.Re-establishing the balance of growth factors maybe one of the mechanisms of TP in the treatment of arthritis.
5.Prediction of response of collagen-induced arthritis rats to methotrexate: an (1)H-NMR-based urine metabolomic analysis.
Zhe CHEN ; Shenghao TU ; Yonghong HU ; Yu WANG ; Yukun XIA ; Yi JIANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(3):438-443
Over one half the patients with rheumatoid arthritis (RA) are being treated with methotrexate (MTX). Although well proven, the efficacy of MTX varies in individual patients. This study examined the metabolic biomarkers that can be used to predict the therapeutic effect of MTX by using metabolomic analysis. Rats were immunized with collagen to rapidly cause collagen-induced arthritis (CIA) and then treated with 0.1 mg/kg MTX for 4 weeks. The clinical signs and the histopathological features of CIA were observed to evaluate the therapeutic effects. Urine samples of CIA rats were collected, and analyzed by using 600 M (1)H-nuclear magnetic resonance ((1)H-NMR) for spectral binning after the therapy. The urine spectra were divided into spectral bins, and 20 endogenous metabolites were assigned by Chenomx Suite. Multivariate analyses were performed to identify the spectral pattern of endogenous metabolites related to MTX therapy. The results showed that the clustering of the spectra of the urine samples from the responsive rats (n=20) was different from that from the non-responsive rats (n=11). Multivariate analysis showed difference in metabolic profiles between the responsive and non-responsive rats by using partial least squares-discrimination analysis (PLS-DA) (R(2)=0.812, Q(2)=0.604). In targeted profiling, 13 endogenous metabolites (uric acid, taurine, histidine, methionine, glycine, etc.) were selected as putative biomarkers for predicting therapeutic response to MTX. It was suggested that (1)H-NMR-based metabolomic analysis can be used to predict the therapeutic effect of MTX, and several metabolites were found to be related to the therapeutic effects of MTX.
Animals
;
Antirheumatic Agents
;
administration & dosage
;
Arthritis
;
chemically induced
;
drug therapy
;
urine
;
Biomarkers
;
urine
;
Collagen Type II
;
Dose-Response Relationship, Drug
;
Immunosuppressive Agents
;
administration & dosage
;
Magnetic Resonance Spectroscopy
;
methods
;
Male
;
Metabolome
;
Methotrexate
;
administration & dosage
;
Proteome
;
analysis
;
Protons
;
Rats
;
Rats, Sprague-Dawley
;
Reproducibility of Results
;
Sensitivity and Specificity
;
Treatment Outcome
6.Design and application of a new heat-and-moisture exchanger with anti-splash sputum suctioning function
Zhiyuan FAN ; Liufang XU ; Zhonghua SHAO ; Huijie YU ; Shenghao GUI
Chinese Critical Care Medicine 2022;34(11):1206-1208
In the emergency department, open endotracheal suctioning for mechanically ventilated patients with endotracheal intubation will lead to the spread of respiratory droplets and aerosols, polluting the surrounding environment and medical staff. The traditional heat-and-moisture exchanger has the effect of warming and humidifying, and can block pathogenic microorganisms, but it does not have the function of inserting a sputum suction tube. When the heat-and-moisture exchanger is pulled out for sputum suction, it is easy to cause sputum splash, which pollutes the surrounding environment and medical personnel. The addition of closed sputum suction devices will increase the economic burden on patients. Thus, the medical staff of emergency department of the First People's Hospital of Tongxiang City of Zhejiang Province designed a new type of heat-and-moisture exchanger with anti-splash sputum suctioning function and obtained the National Utility Model Patent of China (ZL 2021 2 0017615.0). The new heat-and-moisture exchanger is mainly composed of a receiving cavity, a connecting tube, a sputum suction tube intubation tube, a sealing valve, etc. The disposable sputum suction tube can be used to insert sputum suction, and at the same time, it can prevent the secretion from splashing to ensure sealing. The patent combines the humidification and pathogen blocking functions of the heat-and-moisture exchanger with the anti-splash sputum suctioning function, which is suitable for use in the emergency and critical care medicine departments and has clinically practical value.
7.Dietary exposure assessment of chlorate in infant formula
Shenghao YU ; Yiqi LI ; Lujing ZHANG ; Changchang YAN ; Shaojie PENG
Shanghai Journal of Preventive Medicine 2022;34(5):401-406
ObjectiveTo investigate chlorate contamination level in infant formula sold in Shanghai, and to evaluate the dietary exposure risk to infants in Shanghai. MethodsWith the risk monitoring data of chlorate in infant formula sold in Shanghai in 2020, combined with the dietary consumption data of infants, the dietary exposure of chlorate in infant formula was assessed via the point assessment method. ResultsIn 2020, the overall detection rate of chlorate in 120 infant formula samples was 98.3% (118/120), the mean content was 124.5 μg⋅kg-1, the 50 percentile value was 64.6 μg⋅kg-1, and the maximum value was 1 475.0 μg⋅kg-1. The mean and 95 percentile value of daily chlorate intake from infant formula for infants aged 0‒36 months in Shanghai were 1.10 and 1.84 μg⋅kg-1, accounting for 36.7% and 61.3% of the tolerable daily intake (TDI) of chlorate (3μg⋅kg-1), respectively. The mean, 50 percentile value and 95 percentile value of daily chlorate exposure of infants in different month-age groups (0‒6 months, 6‒12 months, 12‒36 months) through infant formula were lower than the TDI value. ConclusionThe health risk of daily chlorate intake from infant formula for infants and young children aged 0‒36 months in Shanghai is at an acceptable level.
8.Dietary exposure assessment of deoxynivalenol in wheat flour and its products sold in Shanghai
Shenghao YU ; Yiqi LI ; Lujing ZHANG ; Shaojie PENG
Shanghai Journal of Preventive Medicine 2023;35(8):729-734
ObjectiveTo investigate the pollution level of deoxynivalenol (DON) in wheat flour and its products sold in Shanghai, and to assess the health risks of DON exposure for residents in Shanghai who ingested DON from wheat flour and its products. MethodsRisk monitoring data of DON in wheat flour and its products sold in Shanghai from 2017 to 2021 were combined with the consumption data of wheat flour and its products by Shanghai residents. A probabilistic assessment method was used to assess dietary exposure of DON in wheat flour and its products. ResultsThe overall detection rate of DON in wheat flour and its products was 77.3% (1 041/1 347), with a mean concentration of 226.3 μg·kg-1, P50 of 130.0 μg·kg-1 and a maximum value of 3 080.0 μg·kg-1. The mean daily exposure and 95th percentile daily exposure (by body weight) of DON from wheat flour and its products in Shanghai residents were 0.279 μg·kg-1 and 1.146 μg·kg, accounting for 27.9% and 114.6% of the daily tolerable intake of DON TDI, 1 μg·kg, respectively. The probability assessment results indicated that 6.1% of the whole population in Shanghai had DON exposure exceeding the TDI value. Among them, 12.8% of the population aged 6 years old and below, 16.4% of the population aged between 7 and 17 years old, 3.9% of the population aged between 18 and 59 years old and 3.2% of the population aged 60 years old and above exceeded the TDI value for daily DON exposure through wheat flour and its products. ConclusionCertain populations in Shanghai may face certain health risks from daily DON intake wheat flour and its products. Special attention should be paid to the health risk of daily DON exposure through wheat flour and its products for individuals age below 18 years old .
9.Assessment of dietary exposure to nonylphenol in infant formula retailed in Shanghai
Yiqi LI ; Shenghao YU ; Lujing ZHANG ; Shaojie PENG
Shanghai Journal of Preventive Medicine 2023;35(8):740-744
ObjectiveTo assess the health risk of dietary exposure to nonylphenol in infants aged 0-36 months through infant formula in Shanghai. MethodsA monitoring of nonylphenol pollution in infant formula was conducted in 2022. A total of 90 samples were obtained from maternal and infant stores, supermarkets, and online stores in Shanghai. Based on the daily consumption data of infant formula, a point assessment method was used to assess the dietary exposure to nonylphenol in infant formula. ResultsThe prevalence of nonylphenol in infant formula retailed in Shanghai was 95.6% (86/90). The amount of nonylphenol varied from non-detected to 22.70 μg·kg-1, with the mean value of 8.47 μg·kg-1 and the P50 value of 7.77 μg·kg-1. The mean daily nonylphenol exposure (estimated by body weight) from infant formula in infants aged 0-6 months, 7-12 months and 13-36 months in Shanghai was 0.091, 0.068 and 0.054 μg·kg-1, respectively; furthermore, the P95 value of daily exposure (by body weight) was 0.228, 0.152 and 0.119 μg·kg-1, respectively. These amounts were much lower than the tolerable daily intake (TDI) of nonylphenol (by body weight 5 μg·kg-1). ConclusionThe health risk of daliy nonylphenol intake from infant formula remains low among infants aged 0-36 months in Shanghai.
10.Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular carcinoma.
Chao GAO ; Shenghao WANG ; Weiqing SHAO ; Yu ZHANG ; Lu LU ; Huliang JIA ; Kejin ZHU ; Jinhong CHEN ; Qiongzhu DONG ; Ming LU ; Wenwei ZHU ; Lunxiu QIN
Frontiers of Medicine 2022;16(3):467-482
Cabozantinib, mainly targeting cMet and vascular endothelial growth factor receptor 2, is the second-line treatment for patients with advanced hepatocellular carcinoma (HCC). However, the lower response rate and resistance limit its enduring clinical benefit. In this study, we found that cMet-low HCC cells showed primary resistance to cMet inhibitors, and the combination of cabozantinib and mammalian target of rapamycin (mTOR) inhibitor, rapamycin, exhibited a synergistic inhibitory effect on the in vitro cell proliferation and in vivo tumor growth of these cells. Mechanically, the combination of rapamycin with cabozantinib resulted in the remarkable inhibition of AKT, extracellular signal-regulated protein kinases, mTOR, and common downstream signal molecules of receptor tyrosine kinases; decreased cyclin D1 expression; and induced cell cycle arrest. Meanwhile, rapamycin enhanced the inhibitory effects of cabozantinib on the migration and tubule formation of human umbilical vascular endothelial cells and human growth factor-induced invasion of cMet inhibitor-resistant HCC cells under hypoxia condition. These effects were further validated in xenograft models. In conclusion, our findings uncover a potential combination therapy of cabozantinib and rapamycin to combat cabozantinib-resistant HCC.
Anilides/pharmacology*
;
Animals
;
Carcinoma, Hepatocellular/drug therapy*
;
Cell Line, Tumor
;
Cell Proliferation
;
Endothelial Cells/metabolism*
;
Humans
;
Liver Neoplasms/drug therapy*
;
Pyridines/pharmacology*
;
Sirolimus/pharmacology*
;
Xenograft Model Antitumor Assays